Cerebrospinal fluid and plasma viral load in HIV-1-infected patients with various anti-retroviral treatment regimens

Scandinavian Journal of Infectious Diseases

Volumn 32, Issue 4, 2000, Pages 365-369

  Gisslen, M ^a   Svennerholm, B ^a   Norkrans, G ^a   Franzen, C ^a   Sall, C ^a   Svensson, R ^a   Oberg, S ^a   Hagberg, L ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PLASMA; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0033853163     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655400750044926     Document Type: Article

References (24)

1. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior anti-retroviral therapy
2. HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir
3. Clinical progression and virological failure on highly active anti-retroviral therapy in HIV-1 patients: A prospective cohort study. Swiss HIV Cohort Study
4. Stability of human immunodeficiency virus RNA in blood specimens as measured by a commercial PCR-based assay
5. The effect on cerebrospinal fluid HIV RNA levels after initiation of zidovudine or didanosine
6. Decay characteristics of HIV-1-infected compartments during combination therapy
7. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection
8. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels
9. Cerebrospinal fluid viral load in HIV-1-infected patients without anti-retroviral treatment: A longitudinal study
10. Time course of cerebrospinal fluid responses to anti-retroviral therapy: Evidence for variable compartmentalization of infection
11. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment
12. Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype
13. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues
14. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
15. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
16. Cerebrospinal fluid HIV-1 RNA levels: Correlation with HIV encephalitis
17. Distribution of brain HIV load in AIDS
18. Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV
19. Study on didanosine concentrations in cerebrospinal fluid. Implications for the treatment and prevention of AIDS dementia complex
20. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudineor stavudine
21. Indinavir in cerebrospinal fluid of HIV-1-infected patients
22. Plasma and cerebrospinal fluid saquinavir concentrations in patients receiving combination anti-retroviral therapy
23. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex
24. The entry of antiviral and anti-retroviral drugs into the central nervous system